Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 64,000 |
5 mg | 在庫あり | ¥ 159,000 |
10 mg | 在庫あり | ¥ 227,000 |
25 mg | 在庫あり | ¥ 335,000 |
50 mg | 在庫あり | ¥ 454,500 |
100 mg | 在庫あり | ¥ 613,000 |
説明 | CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia. |
分子量 | 235.3 |
分子式 | C9H17NO4S |
CAS No. | 88096-02-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CBHcy 88096-02-0 Metabolism Transferase Inhibitor inhibitor inhibit